Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01704833 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy for Paranoia in Schizophrenia
A NA study of Paranoid Delusions, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT01704833 is a NA study of Paranoid Delusions that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01704833, a NA study of Paranoid Delusions, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of this study is to determine the preliminary efficacy of Paranoia-Focused Cognitive Behavioral Therapy (PFCBT) relative to standard care in the treatment of persecutory delusions in patients diagnosed with schizophrenia or schizoaffective Disorder.
Conditions Studied
Interventions
- BEHAVIORAL Paranoia-Focused Cognitive Behavioral Therapy (PFCBT)
Study Locations (1)
New York
- Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2006-09 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01704833
The ClinicalTrials.gov registry entry for NCT01704833 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Paranoid Delusions appearing as the primary indexed condition, and to 1 intervention - of which Paranoia-Focused Cognitive Behavioral Therapy (PFCBT) is the first listed.
NCT01704833 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01704833 about?
NCT01704833 is a clinical study titled "Cognitive Behavioral Therapy for Paranoia in Schizophrenia". The main objective of this study is to determine the preliminary efficacy of Paranoia-Focused Cognitive Behavioral Therapy (PFCBT) relative to standard care in the treatment of persecutory delusions in patients diagnosed with schizophrenia or schizoaffective Disorder.
What is the current status of trial NCT01704833?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2006-09. Estimated completion is 2017-06.
What conditions does trial NCT01704833 study?
This clinical trial studies the following conditions: Paranoid Delusions.
What interventions are being tested in trial NCT01704833?
The interventions under investigation include: Paranoia-Focused Cognitive Behavioral Therapy (PFCBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01704833?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01704833 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.